LONG-TERM EFFICACY AND SAFETY PROFILE OF EZETIMIBE10MG IN TREATMENT OF PATIENTS WITH HOMOZYGOUS SITOSTEROLEMIA: A MULTI-CENTER, OPEN-LABEL, 2-YEAR EXTENSION STUDY

被引：0
|
作者：
Luetjohann, D. [1 ]
von Bergmann, K. [1 ]
Sirah, W. [2 ]
Shah, A. [2 ]
Lin, J. [2 ]
Sapre, A. [2 ]
Johnson-Levonas, A. [2 ]
Musliner, T. [2 ]
机构：
[1] Univ Bonn, Dept Clin Pharmacol, D-5300 Bonn, Germany
[2] Merck Res Labs, Rahway, NJ USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2008年 / 9卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：189 / 189
页数：1
相关论文
共 50 条
  • [1] Long-term efficacy and safety profile of ezetimibe 10 mg in the treatment of patients with homozygous sitosterolemia: A multi-center, open-label, 2-year extension
    Musliner, Thomas
    Sirah, Waheeda
    Shah, Arvind
    Lin, Jianxin
    Sapre, Aditi
    Levonas, Amy Johnson
    Luetjohann, Dieter
    vonBergmann, Klaus
    CIRCULATION, 2007, 116 (16) : 93 - 93
  • [2] Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia:: a 2-year, open-label extension study
    Luetjohann, D.
    von Bergmann, K.
    Sirah, W.
    Macdonell, G.
    Johnson-Levonas, A. O.
    Shah, A.
    Lin, J.
    Sapre, A.
    Musliner, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (10) : 1499 - 1510
  • [3] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    Coghill, D.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 105 - 105
  • [4] Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
    Santos, Raul D.
    Duell, P. Barton
    East, Cara
    Guyton, John R.
    Moriarty, Patrick M.
    Chin, Wai
    Mittleman, Robert S.
    EUROPEAN HEART JOURNAL, 2015, 36 (09) : 566 - 575
  • [5] Tofacitinib in patients with moderate to severe chronic plaque psoriasis: 2-year efficacy and safety in an open-label long-term extension study
    Paul, Carle
    Langley, Richard G.
    Valenzuela, Fernando
    Cather, Jennifer
    Gardner, Annie
    Proulx, James
    Tan, Huaming
    Wolk, Robert
    Kaur, Mandeep
    Rottinghaus, Scott
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB278 - AB278
  • [6] Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension study
    Haab, Francois
    Corcos, Jacques
    Siami, Paul
    Glavind, Karin
    Dwyer, Peter
    Steel, Michael
    Kawakami, Fernando
    Lheritier, Karine
    Steers, William D.
    BJU INTERNATIONAL, 2006, 98 (05) : 1025 - 1032
  • [7] Efficacy, tolerability and safety of long-term darifenacin treatment in older patients with overactive bladder: Analysis of results from a 2-year, open-label extension study
    Dwyer, P.
    Lheritier, K.
    Steel, M.
    NEUROUROLOGY AND URODYNAMICS, 2006, 25 (06) : 657 - 658
  • [8] Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study
    Lugogo, Njira
    Domingo, Christian
    Chanez, Pascal
    Leigh, Richard
    Gilson, Martyn J.
    Price, Robert G.
    Yancey, Steven W.
    Ortega, Hector G.
    CLINICAL THERAPEUTICS, 2016, 38 (09) : 2058 - 2070
  • [9] LONG-TERM SAFETY AND EFFICACY OF SER120 1.5 MCG IN PATIENTS WITH NOCTURIA: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY
    MacDiarmid, Scott
    Nicandro, J. P.
    Cheng, Maria
    Abrams, Steven
    Fein, Seymour
    Wein, Alan
    JOURNAL OF UROLOGY, 2017, 197 (04): : E398 - E398
  • [10] Long-term treatment with zonisamide: Results of a 2 year open-label extension study
    Wroe, S.
    Duncan, R.
    EPILEPSIA, 2006, 47 : 138 - 138
12345